siRNA closed-world re-score — 2026-08-09

16/32 assets (50%) · 11/12 deals (92%) against the frozen Sanofi gold deck (archived_data/cardiometabolic_rnai_gold/), scored by scripts/utils/inspect_sirna_seed.py on main against a copy of ogur_sirna_gpatents_20260625.db (52,228 signals for cardiometabolic-rnai-001).

This run replaces the 2026-06-29 rerun (16/32 · 10/12 as published), whose artifact directory was cited by the benchmark registry but never committed. The asset number is unchanged; the deal count improves by one because this corpus copy carries the EPO patent layer (7,418 signals) alongside gpatents. The remaining miss is deal D09 (Lilly): no same-signal, cross-filing or code match in the corpus.

Recovered assets (16)

A01 BEBT-701, A02 ARO-DIMER-PA, A03 RNS681, A09 SR122, A10 BSA204, A11 HS-02, A12 STP237G, A14 2MW7141, A16 + A17 (Hengrui duals), A26 VERVE-101/102, A27 (Alnylam AGT/ANGPTL3), A29 BW-00112, A30 YS2302018 + AZD0780, A31 Enlicitide + MK-7262, A32 obicetrapib + Repatha.

Missed assets (16)

A04, A05, A06, A07, A08, A13, A15, A18, A19, A20, A21, A22, A23, A25, A28, A33 — predominantly undisclosed or code-only Chinese and preclinical programmes with no registry, filing, or patent footprint in the frozen corpus.

Artifacts: archived_data/cw_rerun_20260809/ (per-asset x source dump, per-deal dump, README with census + repro command).